The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cancer Drug Therapy Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Cancer Drug Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Cancer Drug Therapy market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Angiogenesis Inhibitors accounting for % of the Cancer Drug Therapy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Targeted Therapy segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Cancer Drug Therapy include Amgen / Allergan, Argos Therapeutics, AstraZeneca, Aveo Pharmaceuticals, and Bayer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Cancer Drug Therapy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Targeted Therapy
Chemotherapy
Immunotherapy
Market segment by Application can be divided into
Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy (IL-2)
The key market players for global Cancer Drug Therapy market are listed below:
Amgen / Allergan
Argos Therapeutics
AstraZeneca
Aveo Pharmaceuticals
Bayer
Exelixis
Incyte
Merck
Roche
Bristol-Myers Squibb
Eisai
Exelixis
Genentech (Roche)
Novartis
Pfizer
Prometheus Labs
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cancer Drug Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cancer Drug Therapy, with price, sales, revenue and global market share of Cancer Drug Therapy from 2019 to 2022.
Chapter 3, the Cancer Drug Therapy competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Drug Therapy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Cancer Drug Therapy market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Drug Therapy.
Chapter 13, 14, and 15, to describe Cancer Drug Therapy sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Cancer Drug Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Cancer Drug Therapy market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Angiogenesis Inhibitors accounting for % of the Cancer Drug Therapy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Targeted Therapy segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Cancer Drug Therapy include Amgen / Allergan, Argos Therapeutics, AstraZeneca, Aveo Pharmaceuticals, and Bayer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Cancer Drug Therapy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Targeted Therapy
Chemotherapy
Immunotherapy
Market segment by Application can be divided into
Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy (IL-2)
The key market players for global Cancer Drug Therapy market are listed below:
Amgen / Allergan
Argos Therapeutics
AstraZeneca
Aveo Pharmaceuticals
Bayer
Exelixis
Incyte
Merck
Roche
Bristol-Myers Squibb
Eisai
Exelixis
Genentech (Roche)
Novartis
Pfizer
Prometheus Labs
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cancer Drug Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cancer Drug Therapy, with price, sales, revenue and global market share of Cancer Drug Therapy from 2019 to 2022.
Chapter 3, the Cancer Drug Therapy competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Drug Therapy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Cancer Drug Therapy market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Drug Therapy.
Chapter 13, 14, and 15, to describe Cancer Drug Therapy sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Cancer Drug Therapy Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cancer Drug Therapy Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Targeted Therapy
1.2.3 Chemotherapy
1.2.4 Immunotherapy
1.3 Market Analysis by Application
1.3.1 Overview: Global Cancer Drug Therapy Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Angiogenesis Inhibitors
1.3.3 mTOR Inhibitors
1.3.4 Monoclonal Antibodies
1.3.5 Cytokine Immunotherapy (IL-2)
1.4 Global Cancer Drug Therapy Market Size & Forecast
1.4.1 Global Cancer Drug Therapy Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Cancer Drug Therapy Sales in Volume (2017-2028)
1.4.3 Global Cancer Drug Therapy Price (2017-2028)
1.5 Global Cancer Drug Therapy Production Capacity Analysis
1.5.1 Global Cancer Drug Therapy Total Production Capacity (2017-2028)
1.5.2 Global Cancer Drug Therapy Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Cancer Drug Therapy Market Drivers
1.6.2 Cancer Drug Therapy Market Restraints
1.6.3 Cancer Drug Therapy Trends Analysis
2 Manufacturers Profiles
2.1 Amgen / Allergan
2.1.1 Amgen / Allergan Details
2.1.2 Amgen / Allergan Major Business
2.1.3 Amgen / Allergan Cancer Drug Therapy Product and Services
2.1.4 Amgen / Allergan Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Argos Therapeutics
2.2.1 Argos Therapeutics Details
2.2.2 Argos Therapeutics Major Business
2.2.3 Argos Therapeutics Cancer Drug Therapy Product and Services
2.2.4 Argos Therapeutics Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca Cancer Drug Therapy Product and Services
2.3.4 AstraZeneca Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Aveo Pharmaceuticals
2.4.1 Aveo Pharmaceuticals Details
2.4.2 Aveo Pharmaceuticals Major Business
2.4.3 Aveo Pharmaceuticals Cancer Drug Therapy Product and Services
2.4.4 Aveo Pharmaceuticals Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Cancer Drug Therapy Product and Services
2.5.4 Bayer Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Exelixis
2.6.1 Exelixis Details
2.6.2 Exelixis Major Business
2.6.3 Exelixis Cancer Drug Therapy Product and Services
2.6.4 Exelixis Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Incyte
2.7.1 Incyte Details
2.7.2 Incyte Major Business
2.7.3 Incyte Cancer Drug Therapy Product and Services
2.7.4 Incyte Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Cancer Drug Therapy Product and Services
2.8.4 Merck Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business
2.9.3 Roche Cancer Drug Therapy Product and Services
2.9.4 Roche Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Bristol-Myers Squibb
2.10.1 Bristol-Myers Squibb Details
2.10.2 Bristol-Myers Squibb Major Business
2.10.3 Bristol-Myers Squibb Cancer Drug Therapy Product and Services
2.10.4 Bristol-Myers Squibb Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Eisai
2.11.1 Eisai Details
2.11.2 Eisai Major Business
2.11.3 Eisai Cancer Drug Therapy Product and Services
2.11.4 Eisai Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Exelixis
2.12.1 Exelixis Details
2.12.2 Exelixis Major Business
2.12.3 Exelixis Cancer Drug Therapy Product and Services
2.12.4 Exelixis Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Genentech (Roche)
2.13.1 Genentech (Roche) Details
2.13.2 Genentech (Roche) Major Business
2.13.3 Genentech (Roche) Cancer Drug Therapy Product and Services
2.13.4 Genentech (Roche) Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Novartis
2.14.1 Novartis Details
2.14.2 Novartis Major Business
2.14.3 Novartis Cancer Drug Therapy Product and Services
2.14.4 Novartis Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Pfizer
2.15.1 Pfizer Details
2.15.2 Pfizer Major Business
2.15.3 Pfizer Cancer Drug Therapy Product and Services
2.15.4 Pfizer Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Prometheus Labs
2.16.1 Prometheus Labs Details
2.16.2 Prometheus Labs Major Business
2.16.3 Prometheus Labs Cancer Drug Therapy Product and Services
2.16.4 Prometheus Labs Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Cancer Drug Therapy Breakdown Data by Manufacturer
3.1 Global Cancer Drug Therapy Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Cancer Drug Therapy Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Cancer Drug Therapy
3.4 Market Concentration Rate
3.4.1 Top 3 Cancer Drug Therapy Manufacturer Market Share in 2021
3.4.2 Top 6 Cancer Drug Therapy Manufacturer Market Share in 2021
3.5 Global Cancer Drug Therapy Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Cancer Drug Therapy Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Cancer Drug Therapy Market Size by Region
4.1.1 Global Cancer Drug Therapy Sales in Volume by Region (2017-2028)
4.1.2 Global Cancer Drug Therapy Revenue by Region (2017-2028)
4.2 North America Cancer Drug Therapy Revenue (2017-2028)
4.3 Europe Cancer Drug Therapy Revenue (2017-2028)
4.4 Asia-Pacific Cancer Drug Therapy Revenue (2017-2028)
4.5 South America Cancer Drug Therapy Revenue (2017-2028)
4.6 Middle East and Africa Cancer Drug Therapy Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Cancer Drug Therapy Sales in Volume by Type (2017-2028)
5.2 Global Cancer Drug Therapy Revenue by Type (2017-2028)
5.3 Global Cancer Drug Therapy Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Cancer Drug Therapy Sales in Volume by Application (2017-2028)
6.2 Global Cancer Drug Therapy Revenue by Application (2017-2028)
6.3 Global Cancer Drug Therapy Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Cancer Drug Therapy Sales by Type (2017-2028)
7.2 North America Cancer Drug Therapy Sales by Application (2017-2028)
7.3 North America Cancer Drug Therapy Market Size by Country
7.3.1 North America Cancer Drug Therapy Sales in Volume by Country (2017-2028)
7.3.2 North America Cancer Drug Therapy Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Cancer Drug Therapy Sales by Type (2017-2028)
8.2 Europe Cancer Drug Therapy Sales by Application (2017-2028)
8.3 Europe Cancer Drug Therapy Market Size by Country
8.3.1 Europe Cancer Drug Therapy Sales in Volume by Country (2017-2028)
8.3.2 Europe Cancer Drug Therapy Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Cancer Drug Therapy Sales by Type (2017-2028)
9.2 Asia-Pacific Cancer Drug Therapy Sales by Application (2017-2028)
9.3 Asia-Pacific Cancer Drug Therapy Market Size by Region
9.3.1 Asia-Pacific Cancer Drug Therapy Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Cancer Drug Therapy Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Cancer Drug Therapy Sales by Type (2017-2028)
10.2 South America Cancer Drug Therapy Sales by Application (2017-2028)
10.3 South America Cancer Drug Therapy Market Size by Country
10.3.1 South America Cancer Drug Therapy Sales in Volume by Country (2017-2028)
10.3.2 South America Cancer Drug Therapy Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Cancer Drug Therapy Sales by Type (2017-2028)
11.2 Middle East & Africa Cancer Drug Therapy Sales by Application (2017-2028)
11.3 Middle East & Africa Cancer Drug Therapy Market Size by Country
11.3.1 Middle East & Africa Cancer Drug Therapy Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Cancer Drug Therapy Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Cancer Drug Therapy and Key Manufacturers
12.2 Manufacturing Costs Percentage of Cancer Drug Therapy
12.3 Cancer Drug Therapy Production Process
12.4 Cancer Drug Therapy Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Cancer Drug Therapy Typical Distributors
13.3 Cancer Drug Therapy Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Cancer Drug Therapy Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Cancer Drug Therapy Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Amgen / Allergan Basic Information, Manufacturing Base and Competitors
Table 4. Amgen / Allergan Major Business
Table 5. Amgen / Allergan Cancer Drug Therapy Product and Services
Table 6. Amgen / Allergan Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Argos Therapeutics Basic Information, Manufacturing Base and Competitors
Table 8. Argos Therapeutics Major Business
Table 9. Argos Therapeutics Cancer Drug Therapy Product and Services
Table 10. Argos Therapeutics Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 12. AstraZeneca Major Business
Table 13. AstraZeneca Cancer Drug Therapy Product and Services
Table 14. AstraZeneca Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Aveo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Aveo Pharmaceuticals Major Business
Table 17. Aveo Pharmaceuticals Cancer Drug Therapy Product and Services
Table 18. Aveo Pharmaceuticals Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bayer Basic Information, Manufacturing Base and Competitors
Table 20. Bayer Major Business
Table 21. Bayer Cancer Drug Therapy Product and Services
Table 22. Bayer Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Exelixis Basic Information, Manufacturing Base and Competitors
Table 24. Exelixis Major Business
Table 25. Exelixis Cancer Drug Therapy Product and Services
Table 26. Exelixis Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Incyte Basic Information, Manufacturing Base and Competitors
Table 28. Incyte Major Business
Table 29. Incyte Cancer Drug Therapy Product and Services
Table 30. Incyte Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Merck Basic Information, Manufacturing Base and Competitors
Table 32. Merck Major Business
Table 33. Merck Cancer Drug Therapy Product and Services
Table 34. Merck Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Roche Basic Information, Manufacturing Base and Competitors
Table 36. Roche Major Business
Table 37. Roche Cancer Drug Therapy Product and Services
Table 38. Roche Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 40. Bristol-Myers Squibb Major Business
Table 41. Bristol-Myers Squibb Cancer Drug Therapy Product and Services
Table 42. Bristol-Myers Squibb Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Eisai Basic Information, Manufacturing Base and Competitors
Table 44. Eisai Major Business
Table 45. Eisai Cancer Drug Therapy Product and Services
Table 46. Eisai Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Exelixis Basic Information, Manufacturing Base and Competitors
Table 48. Exelixis Major Business
Table 49. Exelixis Cancer Drug Therapy Product and Services
Table 50. Exelixis Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Genentech (Roche) Basic Information, Manufacturing Base and Competitors
Table 52. Genentech (Roche) Major Business
Table 53. Genentech (Roche) Cancer Drug Therapy Product and Services
Table 54. Genentech (Roche) Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Novartis Basic Information, Manufacturing Base and Competitors
Table 56. Novartis Major Business
Table 57. Novartis Cancer Drug Therapy Product and Services
Table 58. Novartis Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Pfizer Basic Information, Manufacturing Base and Competitors
Table 60. Pfizer Major Business
Table 61. Pfizer Cancer Drug Therapy Product and Services
Table 62. Pfizer Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Prometheus Labs Basic Information, Manufacturing Base and Competitors
Table 64. Prometheus Labs Major Business
Table 65. Prometheus Labs Cancer Drug Therapy Product and Services
Table 66. Prometheus Labs Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Global Cancer Drug Therapy Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 68. Global Cancer Drug Therapy Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 69. Market Position of Manufacturers in Cancer Drug Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 70. Global Cancer Drug Therapy Production Capacity by Company, (K Units): 2020 VS 2021
Table 71. Head Office and Cancer Drug Therapy Production Site of Key Manufacturer
Table 72. Cancer Drug Therapy New Entrant and Capacity Expansion Plans
Table 73. Cancer Drug Therapy Mergers & Acquisitions in the Past Five Years
Table 74. Global Cancer Drug Therapy Sales by Region (2017-2022) & (K Units)
Table 75. Global Cancer Drug Therapy Sales by Region (2023-2028) & (K Units)
Table 76. Global Cancer Drug Therapy Revenue by Region (2017-2022) & (USD Million)
Table 77. Global Cancer Drug Therapy Revenue by Region (2023-2028) & (USD Million)
Table 78. Global Cancer Drug Therapy Sales by Type (2017-2022) & (K Units)
Table 79. Global Cancer Drug Therapy Sales by Type (2023-2028) & (K Units)
Table 80. Global Cancer Drug Therapy Revenue by Type (2017-2022) & (USD Million)
Table 81. Global Cancer Drug Therapy Revenue by Type (2023-2028) & (USD Million)
Table 82. Global Cancer Drug Therapy Price by Type (2017-2022) & (USD/Unit)
Table 83. Global Cancer Drug Therapy Price by Type (2023-2028) & (USD/Unit)
Table 84. Global Cancer Drug Therapy Sales by Application (2017-2022) & (K Units)
Table 85. Global Cancer Drug Therapy Sales by Application (2023-2028) & (K Units)
Table 86. Global Cancer Drug Therapy Revenue by Application (2017-2022) & (USD Million)
Table 87. Global Cancer Drug Therapy Revenue by Application (2023-2028) & (USD Million)
Table 88. Global Cancer Drug Therapy Price by Application (2017-2022) & (USD/Unit)
Table 89. Global Cancer Drug Therapy Price by Application (2023-2028) & (USD/Unit)
Table 90. North America Cancer Drug Therapy Sales by Country (2017-2022) & (K Units)
Table 91. North America Cancer Drug Therapy Sales by Country (2023-2028) & (K Units)
Table 92. North America Cancer Drug Therapy Revenue by Country (2017-2022) & (USD Million)
Table 93. North America Cancer Drug Therapy Revenue by Country (2023-2028) & (USD Million)
Table 94. North America Cancer Drug Therapy Sales by Type (2017-2022) & (K Units)
Table 95. North America Cancer Drug Therapy Sales by Type (2023-2028) & (K Units)
Table 96. North America Cancer Drug Therapy Sales by Application (2017-2022) & (K Units)
Table 97. North America Cancer Drug Therapy Sales by Application (2023-2028) & (K Units)
Table 98. Europe Cancer Drug Therapy Sales by Country (2017-2022) & (K Units)
Table 99. Europe Cancer Drug Therapy Sales by Country (2023-2028) & (K Units)
Table 100. Europe Cancer Drug Therapy Revenue by Country (2017-2022) & (USD Million)
Table 101. Europe Cancer Drug Therapy Revenue by Country (2023-2028) & (USD Million)
Table 102. Europe Cancer Drug Therapy Sales by Type (2017-2022) & (K Units)
Table 103. Europe Cancer Drug Therapy Sales by Type (2023-2028) & (K Units)
Table 104. Europe Cancer Drug Therapy Sales by Application (2017-2022) & (K Units)
Table 105. Europe Cancer Drug Therapy Sales by Application (2023-2028) & (K Units)
Table 106. Asia-Pacific Cancer Drug Therapy Sales by Region (2017-2022) & (K Units)
Table 107. Asia-Pacific Cancer Drug Therapy Sales by Region (2023-2028) & (K Units)
Table 108. Asia-Pacific Cancer Drug Therapy Revenue by Region (2017-2022) & (USD Million)
Table 109. Asia-Pacific Cancer Drug Therapy Revenue by Region (2023-2028) & (USD Million)
Table 110. Asia-Pacific Cancer Drug Therapy Sales by Type (2017-2022) & (K Units)
Table 111. Asia-Pacific Cancer Drug Therapy Sales by Type (2023-2028) & (K Units)
Table 112. Asia-Pacific Cancer Drug Therapy Sales by Application (2017-2022) & (K Units)
Table 113. Asia-Pacific Cancer Drug Therapy Sales by Application (2023-2028) & (K Units)
Table 114. South America Cancer Drug Therapy Sales by Country (2017-2022) & (K Units)
Table 115. South America Cancer Drug Therapy Sales by Country (2023-2028) & (K Units)
Table 116. South America Cancer Drug Therapy Revenue by Country (2017-2022) & (USD Million)
Table 117. South America Cancer Drug Therapy Revenue by Country (2023-2028) & (USD Million)
Table 118. South America Cancer Drug Therapy Sales by Type (2017-2022) & (K Units)
Table 119. South America Cancer Drug Therapy Sales by Type (2023-2028) & (K Units)
Table 120. South America Cancer Drug Therapy Sales by Application (2017-2022) & (K Units)
Table 121. South America Cancer Drug Therapy Sales by Application (2023-2028) & (K Units)
Table 122. Middle East & Africa Cancer Drug Therapy Sales by Region (2017-2022) & (K Units)
Table 123. Middle East & Africa Cancer Drug Therapy Sales by Region (2023-2028) & (K Units)
Table 124. Middle East & Africa Cancer Drug Therapy Revenue by Region (2017-2022) & (USD Million)
Table 125. Middle East & Africa Cancer Drug Therapy Revenue by Region (2023-2028) & (USD Million)
Table 126. Middle East & Africa Cancer Drug Therapy Sales by Type (2017-2022) & (K Units)
Table 127. Middle East & Africa Cancer Drug Therapy Sales by Type (2023-2028) & (K Units)
Table 128. Middle East & Africa Cancer Drug Therapy Sales by Application (2017-2022) & (K Units)
Table 129. Middle East & Africa Cancer Drug Therapy Sales by Application (2023-2028) & (K Units)
Table 130. Cancer Drug Therapy Raw Material
Table 131. Key Manufacturers of Cancer Drug Therapy Raw Materials
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Cancer Drug Therapy Typical Distributors
Table 135. Cancer Drug Therapy Typical Customers
List of Figures
Figure 1. Cancer Drug Therapy Picture
Figure 2. Global Cancer Drug Therapy Revenue Market Share by Type in 2021
Figure 3. Targeted Therapy
Figure 4. Chemotherapy
Figure 5. Immunotherapy
Figure 6. Global Cancer Drug Therapy Revenue Market Share by Application in 2021
Figure 7. Angiogenesis Inhibitors
Figure 8. mTOR Inhibitors
Figure 9. Monoclonal Antibodies
Figure 10. Cytokine Immunotherapy (IL-2)
Figure 11. Global Cancer Drug Therapy Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Cancer Drug Therapy Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Cancer Drug Therapy Sales (2017-2028) & (K Units)
Figure 14. Global Cancer Drug Therapy Price (2017-2028) & (USD/Unit)
Figure 15. Global Cancer Drug Therapy Production Capacity (2017-2028) & (K Units)
Figure 16. Global Cancer Drug Therapy Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Cancer Drug Therapy Market Drivers
Figure 18. Cancer Drug Therapy Market Restraints
Figure 19. Cancer Drug Therapy Market Trends
Figure 20. Global Cancer Drug Therapy Sales Market Share by Manufacturer in 2021
Figure 21. Global Cancer Drug Therapy Revenue Market Share by Manufacturer in 2021
Figure 22. Cancer Drug Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Cancer Drug Therapy Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Cancer Drug Therapy Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Cancer Drug Therapy Sales Market Share by Region (2017-2028)
Figure 26. Global Cancer Drug Therapy Revenue Market Share by Region (2017-2028)
Figure 27. North America Cancer Drug Therapy Revenue (2017-2028) & (USD Million)
Figure 28. Europe Cancer Drug Therapy Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Cancer Drug Therapy Revenue (2017-2028) & (USD Million)
Figure 30. South America Cancer Drug Therapy Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Cancer Drug Therapy Revenue (2017-2028) & (USD Million)
Figure 32. Global Cancer Drug Therapy Sales Market Share by Type (2017-2028)
Figure 33. Global Cancer Drug Therapy Revenue Market Share by Type (2017-2028)
Figure 34. Global Cancer Drug Therapy Price by Type (2017-2028) & (USD/Unit)
Figure 35. Global Cancer Drug Therapy Sales Market Share by Application (2017-2028)
Figure 36. Global Cancer Drug Therapy Revenue Market Share by Application (2017-2028)
Figure 37. Global Cancer Drug Therapy Price by Application (2017-2028) & (USD/Unit)
Figure 38. North America Cancer Drug Therapy Sales Market Share by Type (2017-2028)
Figure 39. North America Cancer Drug Therapy Sales Market Share by Application (2017-2028)
Figure 40. North America Cancer Drug Therapy Sales Market Share by Country (2017-2028)
Figure 41. North America Cancer Drug Therapy Revenue Market Share by Country (2017-2028)
Figure 42. United States Cancer Drug Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Cancer Drug Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Cancer Drug Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Cancer Drug Therapy Sales Market Share by Type (2017-2028)
Figure 46. Europe Cancer Drug Therapy Sales Market Share by Application (2017-2028)
Figure 47. Europe Cancer Drug Therapy Sales Market Share by Country (2017-2028)
Figure 48. Europe Cancer Drug Therapy Revenue Market Share by Country (2017-2028)
Figure 49. Germany Cancer Drug Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Cancer Drug Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Cancer Drug Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Cancer Drug Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Cancer Drug Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Cancer Drug Therapy Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Cancer Drug Therapy Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Cancer Drug Therapy Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Cancer Drug Therapy Revenue Market Share by Region (2017-2028)
Figure 58. China Cancer Drug Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Cancer Drug Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Cancer Drug Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Cancer Drug Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Cancer Drug Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Cancer Drug Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Cancer Drug Therapy Sales Market Share by Type (2017-2028)
Figure 65. South America Cancer Drug Therapy Sales Market Share by Application (2017-2028)
Figure 66. South America Cancer Drug Therapy Sales Market Share by Country (2017-2028)
Figure 67. South America Cancer Drug Therapy Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Cancer Drug Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Cancer Drug Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Cancer Drug Therapy Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Cancer Drug Therapy Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Cancer Drug Therapy Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Cancer Drug Therapy Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Cancer Drug Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Cancer Drug Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Cancer Drug Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Cancer Drug Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Cancer Drug Therapy in 2021
Figure 79. Manufacturing Process Analysis of Cancer Drug Therapy
Figure 80. Cancer Drug Therapy Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
